New dosing schedule could improve sickle cell treatment for kids

NCT ID NCT06578507

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study is testing whether giving hydroxycarbamide (a medicine that helps prevent sickle cell crises) twice a day works better than the usual once-daily dose in children aged 9 months to 11 years with sickle cell disease. About 50 children will take the medicine twice daily for 12 months and have regular clinic visits. The goal is to see if this dosing schedule is safe, how the body processes the drug, and if it improves blood markers like fetal hemoglobin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Centre Hospitalier Intercommunal Créteil

    RECRUITING

    Créteil, France

    Contact

    Contact

  • Centre hospitalier de Cayenne

    RECRUITING

    Cayenne, French Guiana

    Contact

    Contact

  • GHEF- Site de Marne-la-Vallée

    RECRUITING

    Jossigny, France

    Contact Email: •••••@•••••

  • Hôpital Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

    Contact

    Contact

  • Hôpital Necker-Enfants malades

    RECRUITING

    Paris, France

    Contact

    Contact

  • Institut d'Hématologie et d'oncologie pédiatrique - IHOPe

    ACTIVE_NOT_RECRUITING

    Lyon, France

Conditions

Explore the condition pages connected to this study.